期刊文献+

醋氯芬酸缓释片和普通片体内外释药行为的相关性研究 被引量:2

Relativity Study of in Vitro and in Vivo Drug Release for Sustained Release Tablets and Conventional Tablets of Aceclofenac
下载PDF
导出
摘要 目的对比研究醋氯芬酸缓释片和普通片的体外释放行为和Beagle犬体内的药动学,分析体内、体外释药行为的相关性。方法以紫外分光光度法测定两药的体外释放度,利用反相高效液相色谱法测定不同时间Beagle犬血浆中药物浓度,用DAS2.0统计软件计算有关药动学参数,Loo-Riegelman法计算体内吸收百分数,并对体内外相关性进行评价。结果醋氯芬酸缓释片体外恒速释放14h累积释放百分率在95%以上,普通片和缓释片的主要药动学参数达峰时间(tmax)为(2.833±1.169)h和(12.800±0.980)h,血浆半衰期(t1/2)为(2.650±0.261)h和(6.859±6.029)h,峰浓度(Cmax)为(23.457±8.881)μg/mL和(5.674±1.903)μg/mL,药时曲线下面积(AUC0-∞)为(113.171±16.529)μg.h/mL和(128.295±118.601)μg.h/mL,且体内外相关性较好。结论醋氯芬酸缓释片血药浓度平稳,与普通片相比可较长时间保持有效血药浓度。 Objective To compare in vitro release and in vivo pharmacokinetics in Beagle dogs between sustained release tablets and conventional tablets for aceclofenac,and to analyze in vitro-in vivo correlation.Methods In vitro drug release was detected with ultraviolet spectrophotometry and drug concentrations in Beagle dog plasma at different time were tested by RP-HPLC.DAS 2.0 statistical software was used to calculate the pharmacokinetic parameters.Loo-Riegelman method was applied to calculate in vivo absorbing percentage and in vitro-in vivo correlation was evaluated.Results Aceclofenac sustained release tablets constantly released drug for 14 h in vitro and the cumulative release was more than 95%.The major parameters of sustained release tablets and conventional tablets were tmax(2.833±1.169)h and(12.800±0.980)h;t1/2(2.650±0.261)h and(6.859±6.029)h;Cmax(23.457±8.881)μg/mL and(5.674±1.903)μg/mL;AUC0-∞(113.171±16.529)μg·h/mL and(128.295±118.601)μg·h/mL respectively,with a good in vitro-in vivo correlation.Conclusion The blood concentration of aceclofenac sustained release tablets is steady,and its effective blood concentration can be maintained for a long time compared with conventional tablets.
作者 谢魑
出处 《中国药业》 CAS 2010年第9期11-13,共3页 China Pharmaceuticals
关键词 醋氯芬酸 缓释片 普通片 体内 药动学 aceclofenac sustained release tablets conventional tablets in vivo pharmacokinetics
  • 相关文献

参考文献3

  • 1El-Saharty YS,Refaat M,El-Khateeb SZ.Stability-indicating spectrophotometric and densitometric methods for determination of aceclofenac[J].Drug Development and Industrial Pharmacy,2002,28(5):571-582.
  • 2Xu G,Sunada H.Influence of formulation change on drug release kineties from hydroxypropylmethylcellulose matrix tablets[J].Chem Pharm Bull,1995,43(3):483-487.
  • 3刘承统,黄开合,谢林,刘晓东.醋氯芬酸缓释片在犬体内药代动力学及其相对生物利用度研究[J].中国药科大学学报,2004,35(5):443-445. 被引量:4

二级参考文献3

  • 1González-Alvaro I,Carmona L,Díaz-González F,et al.Aceclofenac,a new nonsteroidal antiinflammatory drug,decreases the expression and function or some adhesion molecules on human neutrophils[J].J Rheumatol,1996,23(4):723.
  • 2Kornasoff D,Maisenbacher J,Bowdler J,et al.The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis[J].Rheumatol Int,1996,16(6):225.
  • 3Martín-Mola E,Gijón-Baos J,Ansoleaga JJ,et al.Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthristis[J].Rheumatol Int,1995,15(3):111.

共引文献3

同被引文献42

  • 1谢虹,邱相君,王桂珍.血浆醋氯芬酸测定方法的改进[J].中国公共卫生,2004,20(4):406-407. 被引量:2
  • 2石宁,秦英,黄泓,吕美丽.HPLC法测定醋氯芬酸片有关物质影响因素[J].西北药学杂志,2003,18(6):247-248. 被引量:5
  • 3唐华,王红刚,张晓龙,刘明言.新型非甾体抗炎药醋氯芬酸的研究进展[J].西北药学杂志,2006,21(1):47-48. 被引量:15
  • 4Raghunadha Gupta C, Krishna Kishore G, Vijaya Ratna J. Development and evaluation of aceclofenac matrix tablets using polyethylene oxides as sustained release polymers [J]. Journal of Pharmacy Research ,2013,6 ( 2 ) :249.
  • 5Venkat NR,Rama RN,Naga CK,et al. Design and evaluation of sustained release pellets of aceclofenac [J]. Journal of Pharmacy Research, 2013,6 (5) : 525.
  • 6彭辽宇,廖欢心.非甾体抗炎药的临床应用及不良反应[J].医学信息(下旬刊),2013,26(12):311.
  • 7Jin LD, Wang LR,Wu LQ, et all Effects of COX -2 inhibi- tor on ventilator- induced lung injury in rats [J]. International im- munopharmacology ,2013,16 ( 2 ) :288.
  • 8Mutalik S, Naha A, Usha AN, et al. Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac [J]. Archives of Pharmacal Research,2007,30 (2) :222.
  • 9Lanas A,Garca-Rodrguez LA,Arroyo MT.Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors,traditional non-aspirin non-steroidal antiinflammatory drugs,aspirin and combinations[J].Gut,2006,55(12):1731-1738.
  • 10Blot L,Marcelis A,Devogelaer JP,et al.Effects of diclofenac,aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage[J].British Journal of Pharmacology,2000,131(7):1413-1421.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部